FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020688510> ?p ?o ?g. }

• W2020688510 endingPage "1169" @default.
• W2020688510 startingPage "1165" @default.
• W2020688510 abstract "The aim of this study was to describe the presenting features, the frequency and outcome of myeloid sarcoma (MS) diagnosed in our Institution from January 1995 to December 2000. Twelve MS were seen and the frequency account for only 2% of all acute myeloid leukemia (AML) patients observed in our department in the same period. Median age was 45 years (range: 4-84). All had been initially misdiagnosed as malignant lymphoma (ML) and a median of 2.9 months (range: 1-6) elapsed between the misdiagnosis and the correct of MS, effectuated in our department. At that time, a bone marrow examination revealed a myelodysplastic condition in seven patients, an infiltration by blast cells >30% in two patients, and normal features in the other three. In the non-leukemic patients a median of 5 months (range: 2-44 months) elapsed between the diagnosis of MS and acute leukemia. In all, 10 patients received intensive treatment. A total of seven patients (70%) achieved MS complete remission (CR). Patients who presented isolated skin localization and received only radiotherapy, obtained a MS-CR, but subsequently developed AML. Only in patients who were treated within 4 months from the initial ML diagnosis we achieved complete remission of both MS and leukemia, whereas in patients who were treated after this time, we obtained a complete disappearance of MS without response at the bone-marrow level, irrespectively of the specific therapy regimen. Median survival time from MS diagnosis was 7 months (range: 1-49 months), and only one patient is still alive, 49 months after bone marrow transplantation. Our data stress the importance of an accurate and prompt identification of this rare form of AML, and suggest that, even in patients with isolated MS, the early administration of AML-like intensive chemotherapy followed by bone marrow transplantation might reduce the risk of subsequently developing systemic disease." @default.
• W2020688510 created "2016-06-24" @default.
• W2020688510 creator A5008958861 @default.
• W2020688510 creator A5009095647 @default.
• W2020688510 creator A5016753594 @default.
• W2020688510 creator A5042904167 @default.
• W2020688510 creator A5043985252 @default.
• W2020688510 creator A5051164378 @default.
• W2020688510 creator A5062437293 @default.
• W2020688510 creator A5085720495 @default.
• W2020688510 creator A5089760320 @default.
• W2020688510 creator A5091117889 @default.
• W2020688510 date "2004-11-01" @default.
• W2020688510 modified "2023-10-16" @default.
• W2020688510 title "Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution" @default.
• W2020688510 cites W1827669382 @default.
• W2020688510 cites W1836400534 @default.
• W2020688510 cites W1914559921 @default.
• W2020688510 cites W1949541838 @default.
• W2020688510 cites W1969524960 @default.
• W2020688510 cites W1975019401 @default.
• W2020688510 cites W1985969966 @default.
• W2020688510 cites W1986155348 @default.
• W2020688510 cites W2013951687 @default.
• W2020688510 cites W2017660057 @default.
• W2020688510 cites W2020694922 @default.
• W2020688510 cites W2043003836 @default.
• W2020688510 cites W2043189316 @default.
• W2020688510 cites W2060675585 @default.
• W2020688510 cites W2098854099 @default.
• W2020688510 cites W2169699456 @default.
• W2020688510 cites W2293472245 @default.
• W2020688510 cites W2415127860 @default.
• W2020688510 cites W283165560 @default.
• W2020688510 doi "https://doi.org/10.1016/j.leukres.2004.01.022" @default.
• W2020688510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15380340" @default.
• W2020688510 hasPublicationYear "2004" @default.
• W2020688510 type Work @default.
• W2020688510 sameAs 2020688510 @default.
• W2020688510 citedByCount "95" @default.
• W2020688510 countsByYear W20206885102012 @default.
• W2020688510 countsByYear W20206885102013 @default.
• W2020688510 countsByYear W20206885102014 @default.
• W2020688510 countsByYear W20206885102015 @default.
• W2020688510 countsByYear W20206885102016 @default.
• W2020688510 countsByYear W20206885102017 @default.
• W2020688510 countsByYear W20206885102018 @default.
• W2020688510 countsByYear W20206885102019 @default.
• W2020688510 countsByYear W20206885102020 @default.
• W2020688510 countsByYear W20206885102021 @default.
• W2020688510 countsByYear W20206885102022 @default.
• W2020688510 countsByYear W20206885102023 @default.
• W2020688510 crossrefType "journal-article" @default.
• W2020688510 hasAuthorship W2020688510A5008958861 @default.
• W2020688510 hasAuthorship W2020688510A5009095647 @default.
• W2020688510 hasAuthorship W2020688510A5016753594 @default.
• W2020688510 hasAuthorship W2020688510A5042904167 @default.
• W2020688510 hasAuthorship W2020688510A5043985252 @default.
• W2020688510 hasAuthorship W2020688510A5051164378 @default.
• W2020688510 hasAuthorship W2020688510A5062437293 @default.
• W2020688510 hasAuthorship W2020688510A5085720495 @default.
• W2020688510 hasAuthorship W2020688510A5089760320 @default.
• W2020688510 hasAuthorship W2020688510A5091117889 @default.
• W2020688510 hasConcept C126322002 @default.
• W2020688510 hasConcept C141071460 @default.
• W2020688510 hasConcept C142724271 @default.
• W2020688510 hasConcept C2778256501 @default.
• W2020688510 hasConcept C2778461978 @default.
• W2020688510 hasConcept C2778613593 @default.
• W2020688510 hasConcept C2778729363 @default.
• W2020688510 hasConcept C2779282312 @default.
• W2020688510 hasConcept C2780007613 @default.
• W2020688510 hasConcept C2780817109 @default.
• W2020688510 hasConcept C2781413609 @default.
• W2020688510 hasConcept C509974204 @default.
• W2020688510 hasConcept C71924100 @default.
• W2020688510 hasConceptScore W2020688510C126322002 @default.
• W2020688510 hasConceptScore W2020688510C141071460 @default.
• W2020688510 hasConceptScore W2020688510C142724271 @default.
• W2020688510 hasConceptScore W2020688510C2778256501 @default.
• W2020688510 hasConceptScore W2020688510C2778461978 @default.
• W2020688510 hasConceptScore W2020688510C2778613593 @default.
• W2020688510 hasConceptScore W2020688510C2778729363 @default.
• W2020688510 hasConceptScore W2020688510C2779282312 @default.
• W2020688510 hasConceptScore W2020688510C2780007613 @default.
• W2020688510 hasConceptScore W2020688510C2780817109 @default.
• W2020688510 hasConceptScore W2020688510C2781413609 @default.
• W2020688510 hasConceptScore W2020688510C509974204 @default.
• W2020688510 hasConceptScore W2020688510C71924100 @default.
• W2020688510 hasIssue "11" @default.
• W2020688510 hasLocation W20206885101 @default.
• W2020688510 hasLocation W20206885102 @default.
• W2020688510 hasOpenAccess W2020688510 @default.
• W2020688510 hasPrimaryLocation W20206885101 @default.
• W2020688510 hasRelatedWork W2062542756 @default.
• W2020688510 hasRelatedWork W2070051986 @default.
• W2020688510 hasRelatedWork W2150998544 @default.
• W2020688510 hasRelatedWork W2225205998 @default.

• next